The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow ...

For many years, surgery has been the standard treatment for BPH. However, certain patients, especially those with cardiovascular issues or on blood-thinning medications, may not be suitable ...

This study showed that BPH is a progressive condition that can lead to a worsening of symptoms, acute urinary retention and a need for surgery. Treatment with finasteride alone produced a 50% ...

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Te ...